Does mild COPD affect prognosis in the elderly?

BMC Pulmonary Medicine

Volumn 10, Issue , 2010, Pages

  Pedone, Claudio ^a,b   Scarlata, Simone ^a,b   Sorino, Claudio ^c   Forastiere, Francesco ^d   Bellia, Vincenzo ^c   Antonelli Incalzi, Raffaele ^a,e  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b Fondazione Alberto Sordi   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d ASL RM/E   (Italy)

^e Fondazione San Raffaele Cittadella della Carità ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTHRITIS; ARTICLE; CEREBROVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE CLASSIFICATION; ELDERLY CARE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GERIATRIC DEPRESSION SCALE; HUMAN; HYPERTENSION; INDEPENDENCE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MORTALITY; PHYSICAL CAPACITY; PROGNOSIS; SURVIVAL RATE; AGE DISTRIBUTION; FOLLOW UP; HOSPITALIZATION; PATHOPHYSIOLOGY; PREVALENCE; SURVIVAL;

AGE DISTRIBUTION; AGED; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PREVALENCE; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 77953037563     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-10-35     Document Type: Article

References (27)

1. Diagnosing COPD. Thorax 2004, 59(90001):i27-38., http://thorax.bmj.com/content/59/suppl_1
2. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 2004, 23(6):932-46. PMID: 15219010..
3. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CPM, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 2005, 26(5):948-68. [PMID: 16264058]..
4. Roberts SD, Farber MO, Knox KS, Phillips GS, Bhatt NY, Mastronarde JG, Wood KL. FEV1/FVC ratio of 70% misclassifies patients with obstruction at the extremes of age. Chest 2006, 130:200-6. [PMID: 16840402]., 10.1378/chest.130.1.200, 16840402.
5. Medbö A, Melbye H. Lung function testing in the elderly-Can we still use FEV1/FVC <70% as a criterion of COPD?. Respiratory Medicine 2007, 101(6):1097-1105. 10.1016/j.rmed.2006.11.019, 17239575., http://www.sciencedirect.com/science/article/B6WWS-4MVDVFR-1/2/96e542a12adc0f25465ff7aaa0cf76aa
6. Mannino DM, Buist AS, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?. Thorax 2007, 62(3):237-241. [PMID: 17090573]., 10.1136/thx.2006.068379, 2117148, 17090573.
7. Celli BR, Cote CG, Marin JM, Casanova C, de Oca MM, Mendez RA, Plata VP, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. The New England Journal of Medicine 2004, 350(10):1005-1012. [PMID: 14999112]., 10.1056/NEJMoa021322, 14999112.
8. Bellia V, Pistelli R, Catalano F, Antonelli-Incalzi R, Grassi V, Melillo G, Olivieri D, Rengo F. Quality control of spirom-etry in the elderly. The SA.R.A. study. SAlute Respiration nell'Anziano = Respiratory Health in the Elderly. American Journal of Respiratory and Critical Care Medicine 2000, 161(4Pt1):1094-100. [PMID: 10764296]..
9. Standardization of Spirometry, 1994 Update. American Thoracic Society. American Journal of Respiratory and Critical Care Medicine 1995, 152(3):1107-36. [PMID: 7663792].
10. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. American Journal of Respiratory and Critical Care Medicine 1998, 158(5 Pt 1):1384-1387. [PMID: 9817683]..
11. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 2003, 22(2):268-73. [PMID: 12952259]..
12. Lindberg A, Jonsson A, Rönmark E, Lundgren R, Larsson L, Lundbäck B. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration; International Review of Thoracic Diseases 2005, 72(5):471-9. [PMID: 16210885]..
13. Hansen JG, Pedersen L, Overvad K, Omland T, Jensen HK, Sørensen HT. The Prevalence of chronic obstructive pulmonary disease among Danes aged 45-84 years: population-based study. Copd 2008, 5(6):347-52. [PMID: 19353348]., 10.1080/15412550802522635, 19353348.
14. Lindberg A, Bjerg A, Bjerg-Bäcklund A, Rönmark E, Larsson L, Lundbäck B. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Swe-den Studies. Respiratory Medicine 2006, 100(2):264-272. [PMID: 15975774]., 10.1016/j.rmed.2005.04.029, 15975774.
15. Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, Falaschetti E, Schouten JP, Hankinson JL, Stocks J, Quanjer PH. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction. Thorax 2008, 63(12):1046-1051. [PMID: 18786983]., 10.1136/thx.2008.098483, 18786983.
16. Kuster SP, Kuster D, Schindler C, Rochat MK, Braun J, Held L, Brändli O. Reference equations for lung function screening of healthy never-smoking adults aged 18-80 years. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 2008, 31(4):860-868. [PMID: 18057057]..
17. Roche N, Dalmay F, Perez T, Kuntz C, Vergnenègre A, Neukirch F, Giordanella J, Huchon G. FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision?. Respiratory Medicine 2008, 102(11):1568-74. [PMID: 18657959]., 10.1016/j.rmed.2008.06.007, 18657959.
18. Mannino DM, Doherty DE, Buist AS. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respiratory Medicine 2006, 100:115-22. [PMID: 15893923]., 10.1016/j.rmed.2005.03.035, 15893923.
19. Ekberg-Aronsson M, Pehrsson K, Nilsson J, Nilsson PM, Löfdahl C. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respiratory Research 2005, 6:98. [PMID: 16120227]., 10.1186/1465-9921-6-98, 1224873, 16120227.
20. Celli BR, Cote CG, Lareau SC, Meek PM. Predictors of Survival in COPD: more than just the FEV1. Respiratory Medicine 2008, 102(Suppl 1):S27-35. [PMID: 18582794]., 10.1016/S0954-6111(08)70005-2, 18582794.
21. Bridevaux P, Gerbase MW, Probst-Hensch NM, Schindler C, Gaspoz J, Rochat T. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax 2008, 63(9):768-774. [PMID: 18505800]., 10.1136/thx.2007.093724, 18505800.
22. Calverley PMA, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J, investigators TORCH. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356(8):775-789. 10.1056/NEJMoa063070, 17314337.
23. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Men-joge S, Decramer M, Investigators UPLIFTS. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359(15):1543-1554. 10.1056/NEJMoa0805800, 18836213.
24. Coultas DB, Mapel D, Gagnon R, Lydick E. The health impact of undiagnosed airflow obstruction in a national sample of United States adults. American Journal of Respiratory and Critical Care Medicine 2001, 164(3):372-377. [PMID: 11500335]..
25. Carter R, Holiday DB, Nwasuruba C, Stocks J, Grothues C, Tiep B. 6-minute walk work for assessment of functional capacity in patients with COPD. Chest 2003, 123(5):1408-1415. [PMID: 12740255]., 10.1378/chest.123.5.1408, 12740255.
26. Wijkstra PJ, TenVergert EM, van der Mark TW, Postma DS, Altena RV, Kraan J, Koëter GH. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease. Thorax 1994, 49(5):468-472. [PMID: 8016768]., 10.1136/thx.49.5.468, 474868, 8016768.
27. Pinto-Plata VM, Celli-Cruz RA, Vassaux C, Torre-Bouscoulet L, Mendes A, Rassulo J, Celli BR. Differences in car-diopulmonary exercise test results by American Thoracic Society/European Respiratory Society-Global Initiative for Chronic Obstructive Lung Disease stage categories and gender. Chest 2007, 132(4):1204-1211. [PMID: 17934113]., 10.1378/chest.07-0593, 17934113.